Barrett Esophagus: Clinical Trials

2 trials for Barrett Esophagus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Terminated 1

Follow Barrett Esophagus: new trials by email Literature Review of Barrett Esophagus trials Research Report on Barrett Esophagus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
Chromoendoscopy using Acetic Acid 2.5%, Standard random esophageal biopsies - Barrett's Esophagus
Phase 2 / Phase 3TerminatedDHR Health Institute for Research and Development602017-03-102021-08-27
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Dexlansoprazole, Dexlansoprazole Placebo - Barrett's Esophagus
Phase 2TerminatedTakeda62014-07-012017-05-11

Broader conditions

Digestive System Diseases (2)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Neoplasms (2)  ·  Precancerous Conditions (2)

Interventions

Dexlansoprazole (1)

Sponsors

DHR Health Institute for Research and Development (1)  ·  Takeda (1)

Countries

United States (2)

Top investigators

Ingrid M Chacon, MD (1)